Effective drug delivery through the BTB is one of the greatest therapeutic obstacles in treating brain metastases. Using an experimental
Continue reading »
Home ยป
Erlotinib improves progression-free survival in early mutated non-small cell lung cancer
Neoadjuvant erlotinib benefits selected epidermal growth factor receptor (EGFR)-mutated patients who undergo complete resection of stage IIIA-N2 stage non-small cell
Continue reading »
Drug’s impact on amino acid transporter may offer non-small cell lung cancer patients new hope
An amino acid transporter named xCT may affect the growth and progression of non-small cell lung cancer, a discovery that
Continue reading »